NeuroPace (NPCE) Non-Current Assets (2020 - 2026)
NeuroPace (NPCE) posted quarterly Non-Current Assets of $11.9 million for Q1 2026, down 6.34% year-over-year from $12.7 million in Q1 2025, and up 3.72% quarter-over-quarter from $11.5 million in Q4 2025.
NeuroPace (NPCE) Non-Current Assets (2020 - 2026) Analysis & Trends
NeuroPace's Non-Current Assets history runs 7 years deep, the most recent figure standing at $11.9 million for Q1 2026.
- In Q1 2026, Non-Current Assets fell 6.34% year-over-year to $11.9 million; the TTM figure through Mar 2026 stood at $47.7 million (down 11.5% YoY), while the FY2025 annual figure was $11.5 million, down 13.65% from the prior year.
- Non-Current Assets for Q1 2026 stood at $11.9 million, up from $11.5 million in the prior quarter.
- The five-year high for Non-Current Assets was $16.4 million in Q4 2022, with the low at $6.1 million in Q2 2022.
- The 5-year median for Non-Current Assets is $13.7 million (2024), against an average of $13.1 million.
- The sharpest annual moves came in 2022 and 2025: Non-Current Assets surged 2097.32% in 2022, then fell 13.65% in 2025.
- NeuroPace's Non-Current Assets stood at $16.4 million in 2022, then declined by 8.91% to $14.9 million in 2023, then declined by 10.88% to $13.3 million in 2024, then fell by 13.65% to $11.5 million in 2025, then rose by 3.72% to $11.9 million in 2026.
- Business Quant data shows NPCE's Non-Current Assets at $11.9 million in Q1 2026, $11.5 million in Q4 2025, and $11.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 84.70 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 33.51 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 68.24 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 37.24 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 7.05 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 2.37 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 26.75 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 20.19 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 8.29 Bn |
| 10 | NeuroPace | 479.51 Mn | 427.81 Mn | 18.91 Mn | 10.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.80 Mn |
| Mar 31, 2026 | 11.92 Mn |
| Dec 31, 2025 | 11.49 Mn |
| Sep 30, 2025 | 11.93 Mn |
| Jun 30, 2025 | 12.37 Mn |
| Mar 31, 2025 | 12.73 Mn |
| Dec 31, 2024 | 13.31 Mn |
| Sep 30, 2024 | 13.71 Mn |
| Jun 30, 2024 | 14.16 Mn |
| Mar 31, 2024 | 14.60 Mn |
| Dec 31, 2023 | 14.93 Mn |
| Sep 30, 2023 | 15.33 Mn |
| Jun 30, 2023 | 15.72 Mn |
| Mar 31, 2023 | 16.12 Mn |
| Dec 31, 2022 | 16.39 Mn |
| Sep 30, 2022 | 16.10 Mn |
| Jun 30, 2022 | 6.08 Mn |
| Mar 31, 2022 | 6.56 Mn |
| Dec 31, 2021 | 746,000.00 |
| Sep 30, 2021 | 767,000.00 |